According to researchers, more than 6% of baby boomers tested positive for hepatitis C virus antibodies during a recent 7-month period at a small-city New Jersey ED — twice as high as the CDC estimate for the high-risk group.
Baby boomers born between 1945 and 1965 account for approximately 81% of all patients living with chronic HCV, according to Julia K. Cornett, MD, infectious diseasephysician in the Rutgers Robert Wood Johnson Medical School department of medicine, and colleagues. Since 2013, the United States Preventive Services Task Force has recommended one-time HCV screening for these patients, but testing rates remain low, indicating that national guidelines have had only a minimal impact, Cornett and colleagues said.
The researchers conducted a retrospective cohort study using results from an opt-out HCV screening that targeted baby boomers in a large ED that draws socioeconomically diverse patients from the small New Jersey city where it is located and the surrounding suburbs. They found a high prevalence of HCV in study participants, but also a lower-than-expected overall rate of positive HCV viral load.
Testing for hepatitis C, a major cause of liver cancer, is lagging behind among the group of Americans with the highest rate of infection: baby boomers.
A study published Tuesday showed that only about 13 percent of baby boomers were tested in 2015, up just slightly from 12 percent in 2013. U.S. public health authorities recommend all people in that demographic — those born between 1945 and 1965 — be screened for hepatitis C.
“If we want to make a dent in the rising rate of liver cancer, we need to get the population with a high rate of infection screened and treated,” said Susan Vadaparampil, the study’s senior author and a researcher at Moffitt Cancer Center in Tampa.
Both bills have same goal — to diagnose baby boomers with hep-c — but differ on which providers would be involved
Democratic lawmakers are again seeking to significantly expand testing for hepatitis C, a potentially deadly liver infection that can be successfully treated — assuming it is properly identified.
Two proposals requiring hep-C screening to be offered to certain patients advanced in legislative committees Monday, one in the Assembly and one in the Senate, and both are now set for votes before each full body. More than 8,000 New Jerseyans were diagnosed with the disease in 2015, but an estimated 150,000 are carrying the virus without knowledge.
As part of a statewide hepatitis C prevalence initiative in Georgia, the North Georgia Health District is conducting the Hepatitis C Prevalence Project (HCPP), which is providing data on occurrences of hepatitis C in the health district via free testing to those who are at higher risk of being infected with the virus. This is a two-step process that identifies and supports individuals who are living with the hepatitis C virus (HCV).
Hepatitis C is a contagious and sometimes persistent infection that can lead to lifelong liver disease. The hepatitis C virus is mainly transmitted via contact with blood of an infected person. Most people are unaware they are infected because they don’t look or feel sick.
But the virus can be detected through blood tests. Therefore, the first step in the district’s HCPP process is to identify HCV-infected residents through free rapid hepatitis C virus testing at health departments in Cherokee, Fannin, Gilmer, Murray, Pickens and Whitfield counties. These tests can produce a preliminary result in 20 minutes by using a finger stick test.
One of the biggest problems standing in the way of reducing HIV and hepatitis C (HCV) infections is that patients don’t even know they’re infected. Lucia V. Torian, PhD, of the New York City Department of Health and Mental Hygiene, and colleagues to set out find just how many people presenting to a busy NYC emergency room (ER) are unaware of their status. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, Washington, the team gathered data from
Presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, Washington, the team gathered data from remnant serum of patients who went to the Bronx ER from March 8, 2015 to May 8, 2015.
Blood was drawn from 63% of ER presenters, which is unusually high, according to the researchers. The study was blinded, so participants did not give consent in order to avoid patients’ bias due to perceived risk. All patient identifiers were permanently removed from the database.